Skip to main content
. 2015 Jul 14;4(3):283–296. doi: 10.1007/s40121-015-0075-9

Table 3.

Primary pathogens in patients with positive cultures

Primary pathogens RIE
N = 110, n (%)
LIE
N = 274, n (%)
BRLIE
N = 29, n (%)
Staphylococcus aureus 53 (48.2) 101 (36.9) 11 (37.9)
 Methicillin susceptible 39 (35.5) 50 (18.2) 7 (24.1)
 Methicillin resistant 11 (10.0) 39 (14.2) 3 (10.3)
 Methicillin susceptibility unknown 3 (2.7) 12 (4.4) 1 (3.4)
Coagulase-negative staphylococci
 Staphylococcus epidermidis 30 (27.3) 49 (17.9) 2 (6.9)
  Methicillin susceptible 5 (4.5) 5 (1.8)
  Methicillin resistant 22 (20.0) 37 (13.5) 1 (3.4)
  Methicillin susceptibility unknown 3 (2.7) 7 (2.6) 1 (3.4)
 Other 13 (11.8) 32 (11.7) 6 (20.7)
  Methicillin susceptible 3 (2.7) 5 (1.8) 1 (3.4)
  Methicillin resistant 10 (9.1) 25 (9.1) 2 (6.9)
  Methicillin susceptibility unknown 2 (0.7) 3 (10.3)
Staphylococcus species—coagulase not specified 1 (0.9) 2 (0.7)
Enterococcus faecium 7 (2.6) 1 (3.4)
 Vancomycin susceptible 3 (1.1)
 Vancomycin resistant 2 (0.7) 1 (3.4)
 Vancomycin susceptibility unknown 2 (0.7)
Enterococcus faecalis 6 (5.5) 34 (12.4) 3 (10.3)
 Vancomycin susceptible 5 (4.5) 30 (10.9) 2 (6.9)
 Vancomycin susceptibility unknown 1 (0.9) 4 (1.5) 1 (3.4)
Other Enterococcus species 7 (2.6)
Streptococcus agalactiae or group B streptococci 1 (0.9) 2 (0.7)
Streptococcus dysgalactiae 1 (0.4)
Streptococcus dysgalactiae equisimilis 1 (0.4)
Streptococcus pneumonia 1 (0.4)
Streptococcus pyogenes or group A streptococci 2 (0.7)
Streptococcus species 3 (2.7) 9 (3.3) 1 (3.4)
Viridians streptococci group 3 (2.7) 18 (6.6) 2 (6.9)
Gram-negative bacilli 2 (0.7) 1 (3.4)
Gram-positive cocci 2 (0.7) 1 (3.4)
Othera 4 (1.5) 1 (3.4)

BRLIE both right- and left- sided infective endocarditis, LIE left-sided infective endocarditis, RIE right-sided infective endocarditis

aIncludes Corynebacterium species